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ABSTRACT: The quality of sperm ejaculated by bonnet monkeys
and normal, healthy proven fertile volunteer men, both actively im-
munized with ovine follicle-stimulating hormone (oFSH), was ex-
amined at different times of study for chromatin packaging and ac-
rosomal glycoprotein concentration by flow cytometry. Susceptibility
of sperm nuclear DNA to dithiothreitol (DTT)-induced decondensa-
tion, as measured by ethidium bromide binding, was markedly high
compared with values at day 0 in men and monkeys during periods
when FSH antibody titer was high. Sperm chromatin structure assay
yields t values, which is another index of chromatin packaging.
Higher t values, signifying poor packaging, occurred in both spe-
cies following immunization with heterologous pituitary FSH. The
binding of fluorosceinated pisum sativum agglutinin (PSA-FITC) to
acrosome of sperm of monkeys and men was significantly low, com-
pared with values at day 0 (control) during periods when cross-re-
active FSH antibody titer was high and endogenous FSH was not
detectable. Blockade of FSH function in monkeys by active immu-
nization with a recombinant oFSH receptor protein corresponding to
a naturally occurring messenger RNA (mRNA) also resulted in pro-
duction of sperm with similar defects in chromatin packaging and
reduced acrosomal glycoprotein concentration. Thus, it appears that
in monkeys and men, lack of FSH signaling results in production of
sperm that exhibit defective chromatin packaging and reduction in
acrosomal glycoprotein content. These characteristics are similar to
that exhibited by sperm of some class of infertile men. Interestingly,
these alterations in sperm quality occur well ahead of decreased
sperm counts in the ejaculate.
Key words: Chromatin packaging, FSH deprivation, sperm mat-
uration, infertility.
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Spermatogenesis in mammals is a highly complex pro-cess and is largely regulated by the 2 pituitary go-
nadotropins, follicle-stimulating hormone (FSH) and lu-
teinizing hormone (LH). While the role of LH via its di-
rect control of testicular testosterone secretion remains
undisputed, the function of FSH in the male may vary
according to species. The manner in which FSH regulates
spermatogenesis in rodents appears to be different from
primates, and hence, this has become a topic of many
debates (Zirkin et al, 1994; Moudgal and Sairam, 1998).
A variety of methods have been employed to block FSH
signaling in order to study the regulatory role of FSH on
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rodent spermatogenesis. There is a large body of evidence
in favor and against FSH’s role in regulating spermato-
genesis (Dym et al, 1979; Vaishnav and Moudgal, 1994;
Sinha Hikkim and Swerdloff, 1995; Shetty et al, 1996).
More recent gene disruption studies show that FSH gene
knockout male mice, despite being fertile, show reduction
in testicular size, sperm counts, and sperm motility (Ku-
mar et al, 1997). However, FSH receptor deficient male
mice not only show reduced testes size, sperm counts,
and sperm motility, but also exhibit low testosterone lev-
els. These mutant males also have reduced fertility (Dier-
ich et al, 1998; Sairam et al, unpublished material). How-
ever, these reports on knockout models do not discuss the
possible compensatory mechanisms that may be triggered
in the absence of FSH signaling in the genetically manip-
ulated condition, and extrapolation of such results across
the species can be perilous (Moudgal and Sairam, 1998).
In other species, such as hamsters (Lerchl et al, 1993)
and sheep (Kilgour et al, 1993), completion of spermato-
genesis is dependent on FSH stimulation of testicular
function. Loss of FSH action in sheep leads to decreases
in daily production of B2 spermatogonia, leptotene, and
317Krishnamurthy et al · FSH Deprivation Affects Sperm Quality
pachytene spermatocytes (Kilgour et al, 1993). Studies
reported over the past several years in primates are lead-
ing toward a clear consensus on the need for FSH in
maintaining normal spermatogenesis in monkeys (Murty
et al, 1979; Wickings et al, 1980; Moudgal, 1981; Raj et
al, 1982; Van Alpen et al, 1988; Weinbauer et al, 1991;
Moudgal et al, 1992) and in men (Matsumoto et al, 1986;
Gromoll et al, 1996). In the adult male monkey, FSH
deprivation induced by immunization with heterologous
purified hormone results in impairment of testicular func-
tion leading to reduction in total sperm output (Murty et
al, 1979). Similarly, blockade of FSH receptor function
in male monkeys by an appropriate receptor antibody for-
mation also has been shown to cause testicular dysfunc-
tion and infertility (Moudgal et al, 1997a). Recently, Ta-
panainen et al (1997) analyzed a family of men in Finland
homozygous for an inactivating mutation of FSH receptor
gene. It was observed that these men had a variable de-
gree of spermatogenic failure, and they exhibited oligo-
spermia with poor sperm characteristics. Two out of the
5 men examined, however, were apparently fertile and
had testicular size, FSH levels, and LH levels that were
in the normal range. However, there may not be total in-
activation of the FSH receptor by such point mutations.
From analysis of the inhibin levels of these men, it ap-
pears that there could be some residual receptor activity
to maintain Sertoli cell function. Hence, that situation
does not necessarily represent a condition of complete
loss in FSH signaling. In contrast to this, recent reports
of inactivating mutation of the FSH beta subunit gene
indicate that lack of FSH action is perhaps responsible
for the observed hypogonadism and absence of sperm in
the ejaculate of affected individuals (Lindstedt et al, 1998,
Phillip et al, 1998).
In previous studies in fertile adult male monkeys, we
have shown that continuous bioneutralization of endoge-
nous FSH by either passive or active immunization ap-
proaches leads to oligospermia and infertility (Murty et
al, 1979; Moudgal et al, 1992). In addition to significant
reduction in sperm counts (70%), the poor quality of
the ejaculated sperm exhibited by FSH-immunized mon-
keys contributed to infertility in these males. Analyses of
a variety of parameters such as viability, gross motility,
gel penetrability, and acrosin and hyaluronidase activity
(Moudgal et al, 1992) supported the changes observed in
the quality of spermatogenesis. In addition, it also has
been independently demonstrated that spermatozoa from
FSH-immunized monkeys fail to attach to zona-intact
monkey eggs (Raj et al, 1991) and zona-free hamster eggs
(Srivastava and Das, 1992). Further, we also have ob-
served that FSH deprivation in monkeys affects sperm
chromatin status as determined by the ability of sperm to
undergo nuclear decondensation following exposure to a
reducing agent like dithiothreitol (DTT; Aravindan et al,
1997, and unpublished data). Thus, compromising sper-
matogenesis and its quality at the same time might be-
come an attainable option or consideration for male con-
traception. In the light of these interesting leads it was
considered of interest to apply sensitive-flow cytometric
methods (Spano and Evenson, 1993) to more thoroughly
investigate the chromatin packaging quality of sperm ob-
tained from monkeys and men deprived of endogenous
FSH support by the same immunologic procedure. In the
present study, we have compared the chromatin packag-
ing and acrosomal functionality of sperm of normal, as
well as specifically FSH-deprived, monkeys and men. At
the same time, we have verified whether blocking FSH
receptor at the testicular level can produce similar effects.
A preliminary report of this work was presented at a re-
cent meeting (Krishnamurthy et al, unpublished material).
Materials and Methods
Materials
Dulbecco phosphate-buffered saline solution (PBSS) was ob-
tained from GIBCO Laboratories (Grand Island, NY). DTT, eth-
idium bromide (EB), fluorosceinated pisum sativum agglutinin
(PSA-FITC) and Nonidet P-40 were obtained from Sigma Chem-
ical Co (St Louis, Mo). Pepsin was obtained from Serraferin
Biochemia (Heidelberg, Germany). Acridine Orange (Polysci-
ences, Warrington, Penn) was a kindly gifted by Professor D. P.
Evenson, South Dakota State University, SD. FACScan flow cy-
tometer was obtained from Becton Dickinson (San Jose, Calif).
Monkey Study
The immunization procedure and protocols followed are de-
scribed elsewhere (Moudgal et al, 1992). Briefly, adult male bon-
net monkeys were actively immunized with 1-, 0.3-, 0.1-, and
0.1-mg ovine FSH (oFSH; adsorbed on alhydrogel suspension
given SC) on days 1, 8, 16, and 24. The animals received booster
immunizations once every 90 to 100 days with 0.1 mg of puri-
fied oFSH for more than 5 years. Periodically, blood samples
were collected to assess antibody titer and testosterone and LH
concentrations in the serum. Sperm samples were collected by
electrostimulation, washed twice in PBSS, fixed in chilled 70%
ethanol, and stored at 20C. Similarly, sperm from a group of
3 adult male bonnet monkeys that were rendered infertile be-
cause of immunization for 250 days with a recombinant ovine
FSH receptor protein fragment (oFSHR-P) as described previ-
ously (Moudgal et al, 1997a) were also used for analysis. Sperm
samples from unimmunized normal fertile monkeys collected at
the same time as experimental samples served as corresponding
controls. Control samples also were stored at 20C in 70%
ethanol until further analysis. The sperm samples were obtained
from a group of control (n  3–4) and oFSH-(n  3–4) or
oFSHR-P–(n  3) immunized adult male bonnet monkeys. Tes-
ticular germ cells were obtained by needle biopsy from control
and FSH-immunized monkeys according to procedure outlined
earlier (Aravindan et al, 1993).
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Human Study
Sperm samples collected from 5 volunteer, 34- to 41-year-old,
normal, fertile, healthy men who underwent active immunization
with oFSH as per protocol described earlier (Moudgal et al,
1997b) were used in the study. Briefly, each of the volunteers
received subcutaneous injections of 1 mL Alugel (Alhydrogel,
Superfos, Denmark) suspension containing 1 mg of oFSH on
day 1, and on day 20, a further 1 mL of suspension containing
0.3 mg of oFSH was administered. Booster doses of 0.1 mg of
oFSH were administered on days 40 and 70 of immunization.
The human study was approved by the ethical committee of the
Ramaiah Medical Teaching Hospital, Bangalore, India, where the
clinical study was conducted and each of the volunteers provided
individually signed consent letters. After a 3-day abstinence, the
sperm samples were collected by masturbation between 9 AM
and 11 PM on days 0, 30, 50, 70, and 110 or 140 of immuni-
zation. Because day-110 sample of ejaculate could not be ob-
tained from 1 volunteer, we have used the posttreatment day-
140 sample for all analyses. The volunteer men served as their
own controls, and the sperm samples obtained during a pretreat-
ment control phase and posttreatment recovery phase were com-
pared with those provided during the treatment immunization
phase (Moudgal et al, 1997b). The sperm samples analyzed in
the human study were drawn from pretreatment (day 0), treat-
ment (days 30, 50 and 70), and posttreatment (days 110 and 140)
phases of immunization.
EB Binding to Sperm DNA Following DTT Treatment
The procedure for obtaining sperm nuclear decondensation by
exposure to various concentrations of DTT has been described
earlier (Aravindan et al, 1995, 1997). Briefly, ethanol-fixed
sperm of individual human volunteers and monkeys were
washed twice in PBSS, and the pellet was incubated with 0.2
mL of 0.5% pepsin in PBSS (pH 2) for 10 minutes at 37C.
Samples were washed and treated with 0.01% papain for 5 min-
utes at 37C. In the case of EB-binding studies, each of the
samples were washed, divided into 5 aliquots, and treated with
0, 2.5, 5, 10, and 20 mmol/L DTT (human volunteer) and 0, 2.5,
5, 10, and 50 mmol/L DTT (monkey) respectively for 20 min-
utes at 37C (papain and DTT solutions were prepared in Tris-
HCl buffer, pH 7.2). Following incubation, the samples were
washed, and the sperm pellet was resuspended in 0.5 mL of EB
(EB-staining solution; 25 g EB/mL, 40 g RNAase/mL, and
0.3% Nonidet P-40). The EB-stained samples were analyzed
with a FACScan flow cytometer. The EB-stained sperm were
excited at 488 nm, red fluorescence signals on a linear scale were
collected at 564 to 606 nm, and fluorescence measurement in
peak mode was processed with LYSIS II software.
Testicular germ cells obtained by needle biopsy from control
and FSH-immunized monkeys (Aravindan et al, 1993) also were
tested for DTT-induced decondensation of elongated spermatid
population. Germ cells were exposed to 0 and 5 mmol/L DTT
for 20 minutes at 37C prior to staining with EB, and acquisition
and analysis of fluorescence was done as described above.
Sperm Chromatin Structure Assay
As sperm chromatin structure assay (SCSA) has the advantage
of distinguishing debris from sperm signals (Evenson and Jost,
1994), we analyzed the sperm ejaculated from FSH-immunized
monkeys and men. The dye acridine orange (AO) intercalates
into double-stranded DNA, producing a green fluorescence sig-
nal whereas its binding to single-stranded DNA or RNA causes
a red fluorescence. The SCSA provides an assessment of the
degree of DNA denaturation, which the sperm nucleus under-
goes upon exposure to stringent acid treatment. The extent of
denaturation can be determined by the metachromatic shift from
green to red fluorescence of the AO-stained sperm. The AO-
staining procedure used was essentially similar to that described
by Evenson and Jost (1994). About 0.2 	 106 ethanol-fixed
sperm were washed twice in TNE buffer (0.01 mol/L Tris, 0.15
mol/L NaCl, and 1 mmol/L EDTA, pH 7.4), and the pellet was
resuspended in 200 L TNE and treated with 0.4 mL of acid/
triton X-100 solution (0.15 mol/L NaCl, 0.1 % Triton X-100,
and 0.08 N HCl in double-distilled water). After 30 seconds, 1.2
mL of AO-staining solution (0.15 mol/L NaCl, 0.1 mol/L citric
acid, 0.2 mol/L Na2HPO4, [pH 6] and 6 g/mL AO) was added,
and the stained samples were analyzed with a FACScan flow
cytometer equipped with a 15-mW argon-ion laser. The AO-
stained samples were excited at 488 nm, and the green fluores-
cence was collected at 515 to 545 nm, and the red fluorescence
was collected at 564 to 606 nm and at 605 to 645 nm. Green
and red fluorescence were processed in peak mode of signal with
LYSIS II software. The t values were calculated according the
formula described by Evenson and Jost (1994). The extent of
denaturation was quantitatively denoted by the term t, a value
that can range from 0 to 1. This is a ratio of red fluorescence to
total (green and red) fluorescence (Evenson and Jost 1994). The
higher shift from green to red signifies greater DNA denatur-
ablity and loss of fertility. The t values have shown to be useful
in assessing the fertility rating of bulls (Ballachey et al, 1987,
1988).
Degradation of Sperm DNA
Ethanol-fixed human sperm (at different phases of treatment)
were centrifuged and washed 3 times with PBSS and once with
the lysis buffer (10 mmol/L Tris HCl, pH 8.0; 400 mmol/L NaCl,
and 200 mmol/L EDTA). The cell suspension (1 	 106/mL lysis
buffer) was treated with 10 L proteinase K (20 mg/mL stock)
and 100 L of 10% sodium dodecyl sulfate (SDS) and incubated
at 42C for 24 hours. Nucleic acids in the supernatant of this
digest were precipitated by adding an equal volume of isopro-
panol and storing it at 70C for 6 to 12 hours. The DNA was
washed with 70% ethanol, air-dried, and redissolved in Tris HCl-
EDTA (TE) buffer for digestion with ribonuclease (0.1 mg/mL)
for 3 hours. Following a phenol-chloroform extraction step, the
DNA was again precipitated with ethanol, washed, and air dried.
The final pellet was dissolved in TE buffer and quantitated by
ultraviolet absorbency at 260 nm. Ten micrograms of each sam-
ple was subjected to electrophoresis on a 2% agarose gel at 2V/
cm. The gel was stained with EB for visualization of the migra-
tion pattern. Monkey sperm samples were not available for this
analysis.
Lectin-Binding Property of Sperm
Ethanol-permeabilized monkey and human sperm have been
used to detect acrosomal content by staining with fluorescenated
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Figure 1. Effect of follicle-stimulating hormone (FSH) deprivation on eth-
idium bromide (EB) binding to dithiothreitol (DTT)-treated sperm voided
by man and monkey. See text for experimental details. Asterisk indicates
significantly different (P 
 .05).
lectin (Cross et al, 1986). About 0.2 	 106 ethanol-fixed sperm
were washed 3 times in PBSS, and the pellet was suspended in
100 L of 25 g/mL PSA-FITC for 10 minutes at room tem-
perature in the dark. The period of exposure provided optimal
staining for quantification by flow cytometry, the nonspecific
binding of PSA-FITC being negligible. The sperm were washed
2 times in PBSS to remove excess PSA-FITC and then resus-
pended in 0.5 mL PBSS. The sperm samples obtained from pre-
immunization, treatment (immunization), and postimmunization
phases of human volunteers were stained and analyzed at the
same time. Similarly, sperm from control and oFSH- and
oFSHR-P–immunized monkeys also were processed and ana-
lyzed at the same time. The green fluorescence of the PSA-
FITC–labeled sperm samples were recorded by a FACScan flow
cytometer equipped with argon-ion laser. The sperm samples
were excited at 488 nm, the green signals of FITC on log scale
were collected at 515 to 545 nm, and fluorescence measurement
at peak mode processed on LYSIS II software.
Statistical Analysis
Routinely statistical analysis was performed using Student’s t
test, but wherever necessary, analysis of variance (ANOVA) test
also has been used to determine significance at P 
 .05.
Results
The treatment phase of the human study corresponded to
the period where no free-endogenous FSH was measur-
able by a 2-step radioreceptor assay, and the human FSH
(hFSH) cross-reactive antibody titer was maximal (bind-
ing capacity: 346  185 ng hFSH/mL). While no hFSH
cross-reactive antibody was titratable during the pretreat-
ment control phase, in the posttreatment phase, antibody
titers had fallen to very low levels (binding capacity: 10.5
 5.8 ng hFSH/mL), and free FSH had become detectable
(Moudgal et al, 1997b). In the monkey study, the period
when sperm samples were taken for analysis correspond-
ed with the occurrence of high antibody titers (binding
capacity, 9.1  5.4 g hFSH/mL) in the serum of oFSH-
immunized monkeys (Moudgal et al, 1992). In the case
of oFSHR-P–immunized monkeys, sperm samples were
taken at periods when the serum (IgG fraction) inhibited
the binding of FSH to a test FSH receptor preparation in
vitro by 30% to 80% (Moudgal et al, 1997a). Considering
that the period of immunization in the case of the human
male covered only 1 sperm cycle (70 days), the overall
decrease in sperm counts ranged from 33% to 64%
(Moudgal et al, 1997b). In the case of the monkey study,
the sperm samples obtained were following immunization
with oFSH or oFSHR-P for more than 3 to 4 sperm cycles
(135 days), and as such, the sperm counts were reduced
by more than 75% and 88%, respectively over the control
(Moudgal et al, 1992, 1997a). This also was associated
with a decrease in motility.
Sperm Nuclear Decondensation
The EB-binding pattern of human sperm collected during
treatment phase exhibited significantly (P 
 .04) high
fluorescence compared with sperm of day 0, even in the
absence of DTT (Figure 1A). The sample from day 50 of
immunization was chosen for evaluation of this parame-
ter, because the antibody titer was maximal during this
period. Though the fluorescence intensity of FSH-immu-
nized monkey sperm was higher than its respective con-
trol at 0 concentration of DTT, the increase was not sta-
tistically significant. The mean channel of fluorescence
intensity in the case of human and monkey sperm in-
creased with exposure to increasing concentrations of
DTT (Figure 1A and B). Sperm samples from oFSH-im-
munized men and monkeys had a uniform increase in
susceptibility to DTT-induced decondensation over their
corresponding controls. Maximal and significant differ-
ence became apparent in human samples between 5 to 10
mmol/L DTT (P 
 .02) and in monkey samples between
2.5 to 5.0 mmol/L DTT (P 
 .01). The decrease in the
fluorescence intensity of monkey sperm at 50 mmol/L
concentration of DTT (Figure 1B) may be caused by a
loss of DNA at higher concentrations of DTT. The in-
crease in EB binding correlates to the increase in DTT
concentration (between 0 and 10 mmol/L DTT), and the
r values for control versus immunized groups were 0.85
vs 0.93 for the monkey, respectively, and 0.74 vs 0.84
(day 50) for man, respectively. These results concur with
our earlier observations of increased susceptibility to
DTT-induced decondensation of ejaculated and epididy-
mal sperm from oFSH immunized monkeys (Aravindan
et al, 1997).
Analysis of testicular germ cells of control and oFSH-
immunized monkeys for chromatin status, with DTT-in-
duced decondensability as a parameter, once again re-
vealed that lack of FSH renders the spermatid population
highly susceptible to DTT treatment. The frequency his-
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Figure 2. Representative flow cytograms showing EB-DNA–binding pat-
tern to the elongating/elongated and round spermatid population of testis
of control (top 2 panels) and ovine FSH (oFSH) immunized (bottom 2
panels) monkeys. The testicular germ cell population was exposed to 0
and 5 mmol/L DTT for 20 minutes before staining. N indicates nonspecific
signals; H, hypostainability caused by compaction; HC, elongated sper-
matids; and 1C, round spermatids. For clarity, only the zoomed-in peaks
of HC and 1C are presented.
Figure 3. Mean channel number of the EB-bound elongated spermatid
peak of control (n  4) and FSH-immunized (n  4) monkeys after ex-
posing the germ cells to 5 mmol/L DTT. HC indicates elongated sper-
matid peak; asterisk, significantly different.
tograms obtained for the testicular germ cells treated with
or without DTT are presented (Figure 2). The elongated
spermatids (HC) and round spermatids (1C) peaks of con-
trol and FSH immunized monkeys were essentially iden-
tical in absence of DTT (Figure 2). The mean channel
shift in EB fluorescence of HC population following ex-
posure to 5 mmol/L DTT, however, was significantly dif-
ferent for the 2 groups. Deprivation of FSH resulted in a
2.7-fold (P 
 .01) increase in the mean channel shift com-
pared with corresponding controls (Figure 3). The 1C
population of control monkey testis did not show signif-
icant change in its disposition following DTT treatment
as expected. In the FSH-immunized monkeys, however,
the 1C population also appeared to be susceptible to the
reducing action of DTT. The apparent 1C peak that ap-
pears displaced to the left could be representing both the
true 1C and the HC that have undergone decondensation.
Such a shift to the left in the 1C peak would indicate a
decrease in EB stainability, which could be caused by loss
of DNA following treatment with DTT (Figure 2). Thus,
the spermatid population in the FSH-deprived monkeys
is more susceptible.
Sperm Chromatin Structure Assay
From the AO-binding pattern of sperm ejaculated by
oFSH-immunized volunteer men and monkeys (Figure 4)
it is clear that on a per-cell basis, the red fluorescence
increases, and the green fluorescence decreases with the
progress of immunization. The human data, in addition to
showing that the effect seen is highly reproducible, also
makes it evident that with the fall of hormone antibody
titer (by day 110 or 140) the relative fluorescence inten-
sity pattern shows a reverse trend. While in 2 volunteers
the maximal shift could be seen as early as day 30, in the
other 3 volunteers this effect was evident by day 50. The
t values of the sperm produced by human male volun-
teers significantly (P 
 .0001) increased from a pretreat-
ment control value of 0.31 to 0.54 during treatment phase.
This increase was restored to normalcy (0.32) during the
posttreatment phase (by day 110 or 140 of immunization,
Table 1). The sperm of oFSH-immunized monkeys also
exhibited significantly (P 
 .0001) high t values com-
pared with that of control monkey sperm (Table 1). The
sperm of monkeys rendered infertile because of immu-
nization with the recombinant oFSHR-P (Moudgal et al,
1997b) also showed significantly (P 
 .0001) high t
values compared with controls (Table 1), indicating that
similar effects could be achieved by different methods of
inducing loss of FSH signaling.
Degradation of Sperm DNA
The gel migration pattern of ejaculated sperm DNA sam-
ples from each of the 5 FSH-immunized volunteers are
shown in Figure 5. In this experiment, migration of nu-
cleic acid into the gel is an indication of action of en-
dogenous endonuclease or other effects resulting in cleav-
age. In 4 of the 5 volunteers, the preimmunization sperm
DNA at day 0 either did not migrate or showed slight
mobility, indicating its high molecular weight (compare
10 and 12 with 1 and 5). Only the volunteer No. 9 sample
exhibited a smear pattern on day 0. This could be caused
by some technical problem during sample preparation.
This interpretation is reasonable because the same sample
analyzed for other parameters like SCSA (Figure 4) was
no different compared with day 0 samples of the other 4
volunteers. Interestingly, 50 days after FSH immunization
(ie, when antibody titers were maximum; Moudgal et al,
1997b) the migration of each DNA sample was altered
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Figure 4. Dot plots showing the green (y-axis) and red (x-axis) fluorescence of acridine orange–bound sperm ejaculated by men and monkeys was
determined by sperm chromatin structure assay. Dot plots from 5 individual human volunteers (left panels) on days 0, 30, 50, 70, and 110 or 140
(numbers provided in the right-hand top corner) of oFSH immunization. Representative dot plots showing green and red florescence of acridine
orange–bound sperm voided by control, oFSH, and oFSH receptor protein fragment (oFSHR-P)-immunized monkeys (right panel). In each case,
10 000 cells were analyzed following staining with acridine orange.
Table 1. Sperm chromatin structure assay: t values exhibited by the sperm voided by follicle-stimulating hormone–deprived man and
monkey
Human (n  5)
Phase of Immunization* t Values† (mean  SEM)
Monkey
Immunogen t Values† (mean  SEM)
Pretreatment 0.31  0.001 Control (n  7) 0.24  0.001
Treatment 0.54  0.002‡ oFSH (n  4) 0.35  0.003‡
Posttreatment 0.32  0.002 oFSHR-P (n  3) 0.41  0.002‡
* Day 0 sample from each of the volunteers; t values for control pretreatment phase. During treatment phase (days 30–70), 3 samples per volunteer
were analyzed, and during the posttreatment/recovery phase (days 110 and 140) one sample per volunteer was analyzed.
† t indicates mean channel of red fluorescence/mean channel of green fluorescence  mean channel of red fluorescence; oFSH, ovine follicle-
stimulating hormone; and oFSHR-P, ovine follicle-stimulating hormone receptor protein fragment.
‡ P 
 .0001 pretreatment or control versus treatment.
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substantially, showing a broad smear indicating breakage
of the genetic material. Examination at day 110 or 140,
when FSH-antibody titers had declined, showed a re-
markable recovery of the patterns. During this phase, the
reduced smearing effect indicated an increase in the sta-
bility of DNA, suggesting that the process induced by
deprivation of FSH in circulation is completely reversible.
Because there is no difference in the AO bindability of
sperm ejaculated by volunteer No. 9 on the day 0 (Figure
4), we feel that the DNA degradation observed may be
caused by technical problems while processing the sam-
ple.
Lectin-Binding Property
PSA-FITC binding to sperm quantitated by determining
the mean channel of fluorescence intensity has been used
here to assess the total acrosomal content of glycoprotein
in sperm. Although the frequency histograms of PSA-
FITC-bound sperm from control and immunized men and
monkeys were showing overlaps caused by heterogenity,
the fluorescence intensity (mean channel number) of hu-
man volunteer sperm collected during treatment phase of
immunization showed a significant reduction (by 62%, P

 .001) over corresponding pretreatment controls. The
effect on acrosomal glycoprotein content had not returned
to normalcy even by day 110 to 140 of immunization
(reduced by 55%, P 
 .001). The sperm of monkeys im-
munized either with oFSH or oFSHR-P also showed a
significant reduction (by 39%, P 
 .001 and 55% P 

.04, respectively) in the binding of PSA-FITC over sperm
of control monkeys (Figure 6; Table 2). It should be noted
here that preincubation of control sperm with galactose
reduced PSA-FITC binding to a marked extent. Galac-
tose, which was used as a check of specificity, binds to
the lectin conjugate and prevented subsequent recognition
on cells (data not shown).
Discussion
The primary objective of the current study was to ex-
amine if deprivation of endogenous FSH support in nor-
mal proven fertile men and monkeys produces similar ef-
fects on sperm quality. Among methods currently in use
for assessing sperm quality, flow cytometry techniques
were preferred, because they provide an objective single-
cell analysis with relatively large sample size and more
than 1 parameter of sperm function. Direct comparison
between samples collected on different days of treatment
was feasible because all samples that were used were
fixed in ethanol and stored in cold conditions. The param-
eters we chose for our analysis, such as defective chro-
matin packaging and reduced acrosomal glycoprotein
concentration, have been correlated to infertility in men
and monkeys (Cross et al, 1986; Acosta et al, 1992; Engh
et al, 1992; Kosower et al, 1992; Moudgal et al, 1992;
Bartoov et al, 1994; Bianchi et al, 1996; Sakkas et al,
1996; Aravaindan et al, 1997, Baccetti et al, 1997; Bench
et al, 1998; Kamishke et al, 1998).
Earlier studies in FSH-immunized monkeys had indi-
cated that the observed deleterious changes in the quality
of sperm precede actual reduction in sperm counts in the
ejaculate and induction of infertility (Moudgal et al,
1992). The overall effect is perhaps caused by a marked
decrease in the production of adequate numbers of qual-
itatively normal sperm. In monkeys, Aravindan et al,
(1993, 1997) noted that FSH deprivation reduced sper-
matogonial proliferation and altered spermiogenesis.
Ejaculated and epididymal sperm of FSH-immunized
monkeys bound significantly more 14C-labeled iodoace-
tamide compared with corresponding controls. The failure
of the oFSH-immunized monkey sperm to achieve nucle-
ar compaction that is even equivalent to caput sperm of
normal monkeys, indicated not so much an impaired ep-
ididymal maturation, but rather a distinctly reduced po-
tential for –S–S– bond formation. This is clearly sugges-
tive of defective spermiogenesis (Aravindan et al, 1997).
In the light of the above mentioned studies, it was felt
appropriate to undertake a flow cytometric analysis of
sperm from human volunteers immunized with oFSH.
The results, we felt, could reflect the effectiveness of the
FSH immunization procedure used in the human beings.
Immunization of human volunteers with oFSH led to the
production of antibodies capable of bioneutralizing hFSH
between days 30 and 80 of immunization. During this
period, circulating free FSH was not detected. FSH dep-
rivation led to a marked reduction in seminal plasma
transferrin (in both men and monkeys), used as a marker
of Sertoli cell function (Moudgal et al, 1997b). Coincid-
ing with this are our current observations on changes in
sperm characteristics. It should be noted here that these
changes occurred before large reductions in sperm counts
were observed. In contrast, the monkeys were immunized
with oFSH for more than 3 to 4 sperm cycles before sig-
nificant reduction in sperm counts was observed. Thus, it
is reasonable to propose that reductions in fertility by de-
creasing sperm quality might be possible before affecting
sperm counts.
Sperm maturation, which is initiated at the spermi-
ogenic stage in the testis, continues during transit of the
sperm through the epididymis. During epididymal transit,
the free SH groups of protamines of maturing spermato-
zoa undergo oxidation, resulting in greater degree of con-
densation leading to stabilization of sperm nucleus (Cal-
vin and Bedford, 1971). The susceptibility of the sperm
DNA to acid denaturation in vitro has been correlated
with infertility (Ballachey et al, 1986). Our observation
that the sperm ejaculated by FSH-immunized volunteer
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Figure 5. EB-stained gel showing the DNA degradation pattern of the sperm voided by volunteer men on days 0, 50, and 110 or 140 of immunization.
Smear signified DNA instability. MW indicates DNA molecular weight marker.
men show increased susceptibility to DTT-induced de-
condensation compared with day 0 control sperm (Figure
1) is in line with this conclusion. These changes also are
observed in monkeys (Figure 1; Arvindan et al, 1997).
Other clinical observations also correlate infertility with
improper DNA packaging. Thus, sperm from patients at-
tending an infertility clinic show increased DNA stain-
ability (Engh et al, 1992). Similarly, increase in guanine-
cytosine–specific fluorochrome, chromomycine A3
(CMA3) binding reflects poor packaging quality of human
sperm chromatin. According to Sakkas et al (1996), this
also provides an indirect visualization of protamine defi-
ciency and denaturation of DNA. Bianchi et al (1996),
studying the staining of morphologic characteristics of
normal human sperm with CMA3, observed an inverse
relationship between dye binding and in vitro fertilization.
They also attributed the lowered fertilization rate to the
absence or reduction in protamines and anomaly in chro-
matin packaging. We have demonstrated that this phe-
nomenon can be experimentally induced in monkeys (Fig-
ure 2). Corroborative evidence for FSH deprivation af-
fecting spermiogenic process in primates has been pro-
vided in the current study by analyzing the vulnerability
of the HC population (Figure 3). Thus, it is evident that
changes in packaging are already apparent at the testicular
level in primates.
By use of the more sensitive bivariate SCSA procedure,
both DNA stainability and the degree of DNA denatur-
ation in the sperm can be studied by measuring the meta-
chromatic shift from green to red fluorescence that occurs
following AO binding (Evenson and Jost, 1994). The t
values calculated from the flow cytometric SCSA appears
to show minimal variation within a single group over a
given time. Thus, Evenson (1991) observed that the co-
efficient of variation is as low as 10% for a group of 45
volunteer men over 8 months. In our own experience we
have observed that the t of sperm from proven fertile
men (in addition to the current study) is lower than 0.3.
Generally, in a sperm chromatin structure assay, a 45
angle shift observed in the dot plot or scattergram is
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Figure 6. Fluorosceinated pisum sativum agglutinin (PSA-FITC)-binding pattern of sperm obtained from 5 individual volunteer men (volunteer numbers
are provided in the upper right-hand corner) on days 0, 50, and 110 of immunization with oFSH. For comparison, representative flow cytograms of
the PSA-FITC–binding pattern of sperm from control and oFSH-immunized monkeys also are shown. C indicates control; I, oFSH-immunized monkeys.
Table 2. PSA-FITC binding (acrosomal content of glycoproteins) to sperm of follicle stimulating hormone–deprived man and monkey*
Group Group or Immunization Phase†
Mean Channel of Fluorescence
Intensity, mean  SEM Change, %
Human (n  5) Pretreatment (5)
Treatment (11)
Posttreatment (6)
32.71  2.08
12.37  1.74 c‡
15.00  2.45 d
62
54
Monkey (n  5) Control
oFSH immunized
21.95  0.01
13.41  0.68 c 39
Monkey (n  3) Control
oFSHR-P immunized
66.30  13.75
30.33  6.11 a 54
* Results of each set of experiments carried out independently are shown. oFSH indicates ovine follicle-stimulating hormone; oFSHR-P, ovine follicle-
stimulating hormone receptor protein fragment.
† The numbers in parentheses indicate the total number of samples obtained from 5 volunteers. P values provided are in comparison with respective
controls.
‡ The letter a indicates P 
 .05; b, P 
 .01; c, P 
 .001; d, P 
 .00001.
caused by a relative increase in the red fluorescence and
decrease in the green fluorescence (Evenson and Jost,
1994). In the present study, the percentage of AO-stain-
able sperm (that exhibiting high green and low red fluo-
rescence) showed a drastic reduction with the progress of
immunization reaching a nadir between days 50 and 70
of immunization. However, the percentage of AO-stain-
able sperm returned to normalcy following a drop in the
antibody titer (by days 110–140 of immunization). Sperm
samples from the FSH- as well as FSH-RP–immunized
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monkeys also exhibited reduced AO stainability. There-
fore, it appears from the current study that sperm ejacu-
lated by FSH-immunized men and monkeys are highly
susceptible to the acid-detergent– and DTT-induced de-
naturation of sperm chromatin. In the light of this, any
significant increment in the t values over the day 0 con-
trol becomes meaningful. The high t values exhibited by
the spermatozoa of FSH-deprived men and monkeys over
their respective controls (Table 1) would then indicate that
packaging of chromatin could be poor in both cases be-
cause of protamine deficiency or alteration and denatured
status of DNA. The significant upward shift in the t
values following FSH immunization cannot be ascribed
to reduced DNA stainability, because under such circum-
stances both red and green fluorescence should reduce
proportionally, leading to no change in the ratio. By use
of flow cytometry and application of quadrant analysis to
determine AO binding pattern of ejaculated sperm, it has
been observed that in adult male bonnet monkeys, the
percentage of sperm exhibiting low green-high red fluo-
rescence increased significantly (P 
 .01) from 28% of
control monkeys to 37% of FSH-immunized monkeys
(Aravindan and Moudgal, 1998).
The observation that blockade of FSH action by a spe-
cific FSH receptor antibody also leads to production of
sperm having poor chromatin packaging (higher t val-
ues) lends credence to our thinking that any method that
results in blockade of FSH support in primates signifi-
cantly affects sperm maturation. At present we cannot
rule out the possibility that after exposure to denaturing
agents like DTT (50 mmol/L; Figure 1B) or acid, there
is a loss in the DNA of sperm obtained from FSH-de-
prived monkeys and men. The tertiary and quaternary
structure of protamine-complexed sperm DNA is likely
to be important for the protection of genetic information
and possibly for early genetic events of postfertilization
(Ward and Coffy, 1991). Evenson et al (1993) comment
that even though fertilization could occur with sperm hav-
ing high t value, postfertilization development is ter-
minated prematurely, resulting in early embryonic death.
The t values also have been useful in assessing the fer-
tility rating of bulls (Ballachey et al, 1987, 1988).
The gel electrophoretic pattern of sperm DNA of vol-
unteer men at different times of FSH immunization also
revealed definite degradative patterns (Figure 5). This is
a clear indication of DNA instability, which might be at-
tributed to improper condensation and chromatin pack-
aging allowing action by DNA degradative processes.
Once the immunization effects abated the DNA, as ex-
amined on day 110 or 140 (postimmunization phase), it
reverted to its stable state in 4 out of 5 men. These data
are in complete accord with results of SCSA.
Earlier studies have shown that round spermatids ac-
tively synthesize several glycoproteins (Clermont and
Tang, 1985; Gerton and Milette, 1986) and some of these
(eg, acrosin and hyaluronidase enzymes) are packed into
the acrosome. Acrosomal enzymes are believed to have
crucial roles in fertilization, and lack (partially/complete-
ly) of them could be a cause of infertility (Chulavatnatol,
1990). The PSA-FITC assay we have used is rapid and
useful in detecting the loss of acrosomal contents. Use of
ethanol-permeabilized sperm in this assay provides, de-
spite disruption in sperm membrane, an index of glyco-
protein concentration of acrosome and other cytoplasmic
remnants (Cross et al, 1986). The significant decrease in
the binding of PSA-FITC to the sperm of FSH-deprived
volunteer men and monkeys (following immunization
with oFSH and oFSHR-P, Table 2) compared with their
respective controls would indicate that the acrosomal con-
tent of stainable glycoproteins is reduced in an FSH-de-
ficient state. It is possible that reduction in PSA-FITC
binding in FSH-immunized men and monkeys could be
caused by the alterations in acrosomal glycosylation and
glycoprotein content. This is pertinent because earlier data
showed that acrosin and hyaluronidase activities of sperm
of FSH-deprived monkeys are significantly reduced
(Moudgal et al, 1992) and that the sperm of such animals
are incapable of attaching to intact monkey eggs (Raj et
al, 1991) and zona-free hamster eggs (Srivastava and Das,
1992).
Based on the severity of effect produced on individual
parameters of sperm quality, like acrosomal content of
glycoproteins and chromatin status/packaging in FSH-de-
prived men and monkeys, it would appear that the process
of spermiogenesis in the latter is more sensitive to FSH
deprivation. Whether men, like monkeys, could be ren-
dered infertile by deprivation of endogenous FSH support
for a prolonged period is a question that remains to be
answered. Our phase I study (Moudgal et al 1997b) was
not designed for this purpose.
In conclusion, the current study has shown, for the first
time, that endogenous FSH deprivation in normal men
could affect the chromatin packaging and acrosomal gly-
coprotein concentration of ejaculated sperm, in a manner
very similar to that noticed in monkeys lacking FSH sup-
port. The specificity of the effect in men is underscored
by the fact that it is reversible as restoration to normal
FSH levels leads to regain of normal chromatin packag-
ing.
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